AstraZeneca PLC
1423.50
13-نوفمبر-24 11:24:56
15 متأخرة بدقائق
الأسهم
+15.50
+1.10%
نطاق اليوم
1413.50 - 1446.00
ISIN
N/A
المصدر
Cboe
-
25 أبريل 2024 11:30:48 بحسب NASDAQ US Markets
-
25 أبريل 2024 11:15:48 بحسب NASDAQ Stocks
-
AstraZeneca Q1 Profit, Revenues Climb; Backs FY24 Outlook
25 أبريل 2024 03:16:35 بحسب NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
25 أبريل 2024 03:15:24 بحسب NetDania Notify
-
ANGLE Reaches Deal With AstraZeneca To Advance DDR Assay For Circulating Tumor Cell Detection
24 أبريل 2024 03:37:17 بحسب NASDAQ US Markets
-
FDA Approves AstraZeneca And Daiichi Sankyo's Enhertu For Solid Tumors Treatment
05 أبريل 2024 22:16:14 بحسب NASDAQ US Markets
-
Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
05 أبريل 2024 09:38:12 بحسب NASDAQ Stocks
-
AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod
02 أبريل 2024 10:15:53 بحسب NASDAQ Stocks
-
Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock
26 مارس 2024 18:07:03 بحسب NASDAQ Stocks
-
AstraZeneca Announces FDA Approval For Ultomiris - Quick Facts
25 مارس 2024 03:55:20 بحسب NASDAQ US Markets
-
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
20 مارس 2024 14:32:29 بحسب NASDAQ Stocks
-
AstraZeneca To Buy Fusion Pharma For Up To $2.4 Bln
19 مارس 2024 03:31:51 بحسب NASDAQ US Markets
-
AstraZeneca To Expand Savings Programs For US Inhaled Respiratory Portfolio
18 مارس 2024 07:40:23 بحسب NASDAQ US Markets
-
First Week of AZN May 17th Options Trading
15 مارس 2024 12:39:15 بحسب NASDAQ Stocks
-
AstraZeneca To Buy Amolyt Pharma For Up To $1.05 Bln To Expand Late-stage Rare Disease Pipeline
14 مارس 2024 03:46:14 بحسب NASDAQ US Markets
-
AstraZeneca Announces Initiation Of Phase III Trial With BREZTRI
13 مارس 2024 07:41:44 بحسب NASDAQ US Markets
-
AZN Crosses Above Key Moving Average Level
11 مارس 2024 16:51:21 بحسب NASDAQ US Markets
-
AZN Crosses Above Key Moving Average Level
11 مارس 2024 16:44:19 بحسب NASDAQ Stocks
-
AstraZeneca's Datopotamab Deruxtecan Applications Validated In EU For Lung Cancer, Breast Cancer
04 مارس 2024 03:26:38 بحسب NASDAQ US Markets
-
AstraZeneca: Voydeya Recommended For Approval In The EU By CHMP - Quick Facts
26 فبراير 2024 02:56:02 بحسب NASDAQ US Markets